Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1995;73(4):515–521.

Evaluation of commercial HTLV-1 test kits by a standard HTLV-1 serum panel.

C Fujiyama 1, T Fujiyoshi 1, D Matsumoto 1, H Tamashiro 1, S Sonoda 1
PMCID: PMC2486771  PMID: 7554024

Abstract

To evaluate the performance of currently available test kits for human T-cell lymphotropic virus type 1 (HTLV-1), we examined two particle agglutination (PA) tests and nine enzyme immunoassays (EIA) using a standard serum panel consisting of HTLV-1-positive and HTLV-1-negative sera that had been characterized by immunofluorescence and the polymerase chain reaction (PCR). The PA kits exhibited 94.0-100.0% sensitivity and 99.5-100.0% specificity; the sensitivity range was ascribed to the quality of the HTLV-1 antigens coated on the particles. The EIA kits had 99.5-100% sensitivity and 98.5-100% specificity; the 98.5%-99.5% specificity exhibited by five of the EIA kits could have been due to nonspecific reactions that were detected through use of an inadequate cut-off value and the use of recombinant proteins. It can be concluded that the sensitivity of the currently available PA and EIA kits is sufficient to permit their use for screening purposes; however, the specificity of some EIA kits should be optimized.

Full text

PDF
515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buckner C., Roberts C. R., Foung S. K., Lipka J., Reyes G. R., Hadlock K., Chan L., Gongora-Biachi R. A., Hjelle B., Lal R. B. Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations. J Infect Dis. 1992 Nov;166(5):1160–1163. doi: 10.1093/infdis/166.5.1160. [DOI] [PubMed] [Google Scholar]
  2. Chen Y. M., Zhang X. Q., Dahl C. E., Samuel K. P., Schooley R. T., Essex M., Papas T. S. Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses. J Immunol. 1991 Oct 1;147(7):2368–2376. [PubMed] [Google Scholar]
  3. Crofts N., Maskill W., Gust I. D. Evaluation of enzyme-linked immunosorbent assays: a method of data analysis. J Virol Methods. 1988 Oct;22(1):51–59. doi: 10.1016/0166-0934(88)90087-0. [DOI] [PubMed] [Google Scholar]
  4. Ehrlich G. D., Andrews J., Sherman M. P., Greenberg S. J., Poiesz B. J. DNA sequence analysis of the gene encoding the HTLV-I p21e transmembrane protein reveals inter- and intraisolate genetic heterogeneity. Virology. 1992 Feb;186(2):619–627. doi: 10.1016/0042-6822(92)90028-n. [DOI] [PubMed] [Google Scholar]
  5. Fujino R., Kawato K., Ikeda M., Miyakoshi H., Mizukoshi M., Imai J. Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody. Jpn J Cancer Res. 1991 Apr;82(4):367–370. doi: 10.1111/j.1349-7006.1991.tb01856.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
  7. Hashimoto K., Lalkaka J., Fujisawa J., Singhal B. S., Machigashira K., Kubota R., Suehara M., Osame M., Yoshida M. Limited sequence divergence of HTLV-I of Indian HAM/TSP patients from a prototype Japanese isolate. AIDS Res Hum Retroviruses. 1993 Jun;9(6):495–498. doi: 10.1089/aid.1993.9.495. [DOI] [PubMed] [Google Scholar]
  8. Ikeda M., Fujino R., Matsui T., Yoshida T., Komoda H., Imai J. A new agglutination test for serum antibodies to adult T-cell leukemia virus. Gan. 1984 Oct;75(10):845–848. [PubMed] [Google Scholar]
  9. Inaba S., Sato H., Okochi K., Fukada K., Takakura F., Tokunaga K., Kiyokawa H., Maeda Y. Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience. Transfusion. 1989 Jan;29(1):7–11. doi: 10.1046/j.1537-2995.1989.29189101168.x. [DOI] [PubMed] [Google Scholar]
  10. Khabbaz R. F., Hartley T. M., Lairmore M. D., Kaplan J. E. Epidemiologic assessment of screening tests for antibody to human T lymphotropic virus type I (HTLV-I). Am J Public Health. 1990 Feb;80(2):190–192. doi: 10.2105/ajph.80.2.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kinoshita T., Imamura J., Nagai H., Ito M., Ito S., Ikeda S., Nagatomo M., Tajima K., Shimotohno K. Absence of HTLV-I infection among seronegative subjects in an endemic area of Japan. Int J Cancer. 1993 Apr 22;54(1):16–19. doi: 10.1002/ijc.2910540104. [DOI] [PubMed] [Google Scholar]
  12. Komurian-Pradel F., Pelloquin F., Sonoda S., Osame M., de The G. Geographical subtypes demonstrated by RFLP following PCR in the LTR region of HTLV-I. AIDS Res Hum Retroviruses. 1992 Apr;8(4):429–434. doi: 10.1089/aid.1992.8.429. [DOI] [PubMed] [Google Scholar]
  13. Kubota R., Fujiyoshi T., Izumo S., Yashiki S., Maruyama I., Osame M., Sonoda S. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol. 1993 Feb;42(2):147–154. doi: 10.1016/0165-5728(93)90004-i. [DOI] [PubMed] [Google Scholar]
  14. Lal R. B., Rudolph D. L., Nerurkar V. R., Yanagihara R. Humoral responses to the immunodominant gag and env epitopes of human T-lymphotropic virus type I among Melanesians. Viral Immunol. 1992 Winter;5(4):265–272. doi: 10.1089/vim.1992.5.265. [DOI] [PubMed] [Google Scholar]
  15. Lipka J. J., Miyoshi I., Hadlock K. G., Reyes G. R., Chow T. P., Blattner W. A., Shaw G. M., Hanson C. V., Gallo D., Chan L. Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. J Infect Dis. 1992 Feb;165(2):268–272. doi: 10.1093/infdis/165.2.268. [DOI] [PubMed] [Google Scholar]
  16. Matsumoto C., Mitsunaga S., Oguchi T., Mitomi Y., Shimada T., Ichikawa A., Watanabe J., Nishioka K. Detection of human T-cell leukemia virus type I (HTLV-I) provirus in an infected cell line and in peripheral mononuclear cells of blood donors by the nested double polymerase chain reaction method: comparison with HTLV-I antibody tests. J Virol. 1990 Nov;64(11):5290–5294. doi: 10.1128/jvi.64.11.5290-5294.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nishioka K., Maruyama I., Sato K., Kitajima I., Nakajima Y., Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989 Feb 25;1(8635):441–441. doi: 10.1016/s0140-6736(89)90038-x. [DOI] [PubMed] [Google Scholar]
  18. Ohba N., Matsumoto M., Sameshima M., Kabayama Y., Nakao K., Unoki K., Uehara F., Kawano K., Maruyama I., Osame M. Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol. 1989;33(1):1–12. [PubMed] [Google Scholar]
  19. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986 May 3;1(8488):1031–1032. doi: 10.1016/s0140-6736(86)91298-5. [DOI] [PubMed] [Google Scholar]
  20. Palker T. J., Tanner M. E., Scearce R. M., Streilein R. D., Clark M. E., Haynes B. F. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. J Immunol. 1989 Feb 1;142(3):971–978. [PubMed] [Google Scholar]
  21. Pate E. J., Wiktor S. Z., Shaw G. M., Taylor M. E., Champegnie E., Murphy E. L., Blattner W. A. Lack of viral latency of human T-cell lymphotropic virus type I. N Engl J Med. 1991 Jul 25;325(4):284–284. doi: 10.1056/NEJM199107253250413. [DOI] [PubMed] [Google Scholar]
  22. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415–7419. doi: 10.1073/pnas.77.12.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer. 1990 Feb 15;45(2):237–243. doi: 10.1002/ijc.2910450206. [DOI] [PubMed] [Google Scholar]
  24. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977 Sep;50(3):481–492. [PubMed] [Google Scholar]
  25. Verdier M., Denis F., Leonard G., Sangare A., Patillaud S., Prince-David M., Essex M. Comparison of immunofluorescence, particle agglutination, and enzyme immunoassays for detection of human T-cell leukemia virus type I antibody in African sera. J Clin Microbiol. 1990 Sep;28(9):1988–1993. doi: 10.1128/jcm.28.9.1988-1993.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES